Found: 27
Select item for more details and to access through your institution.
Central Nervous System Disease Progression Among Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Case Series.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Repeat Treatment of Patients With Advanced Urothelial Carcinoma With Immune Checkpoint Inhibitors Following Prior Progression on a Checkpoint Inhibitor Regimen: A Case Series.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Problem of Underrepresentation: Black Participants in Lifestyle Trials Among Patients with Prostate Cancer.
- Published in:
- Journal of Racial & Ethnic Health Disparities, 2020, v. 7, n. 5, p. 996, doi. 10.1007/s40615-020-00724-8
- By:
- Publication type:
- Article
Novel hormonal approaches in prostate cancer.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 3, p. 227, doi. 10.1007/s11912-009-0032-4
- By:
- Publication type:
- Article
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2758-3
- By:
- Publication type:
- Article
The Double-Edged Sword of ADT: Emerging Evidence of Cardiovascular, Pulmonary, and Renal Risks.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
The Double-Edged Sword of ADT: Emerging Evidence of Cardiovascular, Pulmonary, and Renal Risks.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 1, p. 67
- By:
- Publication type:
- Article
When to Use Somatic Tumor Testing in Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, p. 487
- By:
- Publication type:
- Article
Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High‐intensity Aerobic and resistance exercise for Metastatic castrate‐resistant Prostate cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 22, p. 8058, doi. 10.1002/cam4.4324
- By:
- Publication type:
- Article
Initial Experience with <sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266390
- By:
- Publication type:
- Article
Initial Experience with <sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266390
- By:
- Publication type:
- Article
Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84507-z
- By:
- Publication type:
- Article
Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 10, p. 2284, doi. 10.1002/ijc.28561
- By:
- Publication type:
- Article
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Whole Exome Sequencing to Map the Genomic Evolution of Metastatic Prostate Cancer.
- Published in:
- Human Mutation, 2013, v. 34, n. 9, p. iv, doi. 10.1002/humu.22194
- By:
- Publication type:
- Article
A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 656, doi. 10.1634/theoncologist.2017-0624
- By:
- Publication type:
- Article
A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 5, p. 503, doi. 10.1634/theoncologist.2016-0432
- By:
- Publication type:
- Article
Case Report: Clinical Characteristics and Outcomes of HIV Positive Patients With Metastatic Prostate Cancer Treated With Immunotherapy: A Case Series and Literature Review.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.910115
- By:
- Publication type:
- Article
APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.816706
- By:
- Publication type:
- Article
Changes in older adults' life space during lung cancer treatment: A mixed methods cohort study.
- Published in:
- Journal of the American Geriatrics Society, 2022, v. 70, n. 1, p. 136, doi. 10.1111/jgs.17474
- By:
- Publication type:
- Article
Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 1, p. 247, doi. 10.1007/s40487-021-00147-3
- By:
- Publication type:
- Article
Copy number gains at chr3p25 and chr11p11 are associated with lymph node involvement and survival in muscle-invasive bladder tumors.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0187975
- By:
- Publication type:
- Article
Tumor Board: Bladder Cancer.
- Published in:
- AUANews, 2018, p. 17
- By:
- Publication type:
- Article
Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery.
- Published in:
- AUANews, 2018, p. 7
- By:
- Publication type:
- Article